Cell Biology and Multigene Transcriptional Profiling Core
Cell Biology and Multigene Transcriptional Profiling Core
批准号:
8459039
负责人:
John W LAWLER
金额:
$17.64万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-13 至 2015-09-30
关键词:
AntibodiesApoptosisBiological PreservationBreast Cancer CellCancer cell lineCell Culture TechniquesCell CycleCell LineCellsCellular biologyCharacteristicsColon CarcinomaComplementary DNAConsultCultured CellsDataData SetDermalEndothelial CellsEnsureGene ExpressionGene Expression ProfilingGenesGrowthGrowth FactorHeartHumanIndividualLeadLewis Lung CarcinomaLibrariesLungMaintenanceMalignant Epithelial CellMeasurementMeasuresMessenger RNAMolecular ProfilingMonitorMusNamesPhenotypePlayProcessQuality ControlRattusReagentRegulationResearch PersonnelSW480SamplingSerumStatistical Data InterpretationTechniquesTestingTimeUmbilical veinValidationangiogenesisbasedesigndimerfetalglioma cell linemeetingsnovel markerprogramsrepositoryspellingtissue culture
中文摘要
细胞生物学和基因分析核心将提供标准化,同质和良好的表征细胞
人和小鼠来源的培养物提供给各个项目的研究人员。此外,该核心将
提供多基因转录谱分析(MGTP)用于表征培养物和组织中的细胞。
该核心将产生人真皮内皮细胞(HDMEC)、小鼠心脏和肺内皮细胞,
淋巴管内皮细胞和大规模扩增人脐静脉内皮细胞(HUVEC)。
该中心已经开发了一组针对内皮细胞标记的抗体,
在培养物中保存表型,并将作为细胞系的储存库,
地形图细胞生物学和基因分析核心还将负责质量控制测试,
某些关键试剂(例如,胎儿血清、生长因子、培养基)和批量购买这些试剂,
所有项目的使用。该功能确保培养细胞的生长和维持条件一致
从他们的隔离和传播的核心,通过他们的操纵,在各种个人
项目该核心还将培养将在项目中使用的各种癌细胞系。
通过MGTP(多基因转录谱),该核心也可供研究人员使用。
个人项目的设施,精确定量的基因表达。MGTP是一种基因表达
基于使用设计用于均匀扩增的引物的定量实时PCR的谱分析技术
高效率和主cDNA模板,用于多基因组的高实验通量。MGTP是
能够准确且可重复地测定每个细胞表达的mRNA拷贝数。我们米特尔
文库目前包括1000多个不同的人类和小鼠基因,这些基因在人类和小鼠的基因组中发挥关键作用。
血管生成,细胞周期和凋亡,我们将继续增加数百个库
基因每年核心将提供基因图谱数据统计分析方面的专门知识。MGTP
还将用于表征核心制备的HDMEC,以确保批次间的一致性
并开发新的标记。
英文摘要
The Cell Biology and Gene Profiling Core will provide standardized, homogenous and well-characterized cell
cultures of human and mouse origin to the investigators of the individual projects. In addition, this Core will
provide multi-gene transcriptional profiling (MGTP) for the characterization of cells in culture and tissues.
The core will produce human dermal endothelial cells (HDMEC), mouse heart and lung endothelial cells,
ymphatic endothelial cells, and large-scale amplification of human umbilical vein endothelial cells (HUVEC).
The core has developed a panel of antibodies for endothelial cell markersthat will be used to monitor
preservation of phenotype in culture and will function as a repository for cell lines that are generated by the
orogram. The Cell Biology and Gene Profiling Core will also be responsible for quality control testing of
certain key reagents (e.g. fetal serum, growth factors, media) and the bulk purchase of these reagents for
the use of all projects. This function ensures consistent growth and maintenance conditions for cultured cells
from their isolation and propagation within the core through their manipulation in the various individual
projects. This core will also culture the various cancer cell lines that will be used within the project.
Through MGTP (multi-gene transcriptional profiling), this core also makes available to the investigators of the
individual projects a facility for accurate quantification of gene expression. MGTP is a gene expression
profiling technique based on quantitative real-time PCR using primers designed for uniform amplification
efficiencies and a master cDNA template for high experimental throughput for multi-gene panels. MGTP is
capable of accurately and reproducibly measuring mRNA copy numbers expressed per cell. Our primer
library currently includes over 1000 different human and mouse genes that play critical functions in
angiogenesis, the cell cycle, and apoptosis, and we will continue to grow the library by several hundred
genes per year. The Core will provide expertise in the statistical analysis of the gene profiling data. MGTP
will also be used to characterize the HDMEC that are prepared by the core to assure lot-to-lot consistency
and to develop new markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of angiogenesis by thrombospondin-1 (A2)
-
批准号:8193192
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Inhibition of angiogenesis by thrombospondin-1 (A2)
-
批准号:7876959
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Inhibition of angiogenesis by thrombospondin-1 (A2)
-
批准号:8270525
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Thrombospondin 4 A1
-
批准号:7650755
-
项目类别:
-
资助金额:$71.11万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Thrombospondin 4 A1
-
批准号:7851211
-
项目类别:
-
资助金额:$70.19万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Inhibition of angiogenesis by thrombospondin-1 (A2)
-
批准号:7650776
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2009
-
负责人:John W LAWLER
-
依托单位:
Thrombospondins and other Matricellular Proteins in Tissue Organization and Hemeo
-
批准号:7275863
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2007
-
负责人:John W LAWLER
-
依托单位:
Cell Biology and Multigene Transcriptional Profiling Core
-
批准号:8378445
-
项目类别:
-
资助金额:$18.55万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Structure and Function of Thrombospondin-1
-
批准号:6625601
-
项目类别:
-
资助金额:$37.94万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Structure and Function of Thrombospondin-1
-
批准号:6477678
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Cell Biology and Multigene Transcriptional Profiling Core
-
批准号:7617356
-
项目类别:
-
资助金额:$14.38万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Structure and Function of Thrombospondin-1
-
批准号:6719548
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Cell Biology and Multigene Transcriptional Profiling Core
-
批准号:8079647
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Structure and Function of Thrombospondin-1
-
批准号:6868962
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
Cell Biology and Multigene Transcriptional Profiling Core
-
批准号:8259229
-
项目类别:
-
资助金额:$14.14万
-
财政年份:2002
-
负责人:John W LAWLER
-
依托单位:
THROMBOSPONDIN 4
-
批准号:6183224
-
项目类别:
-
资助金额:$34.29万
-
财政年份:1994
-
负责人:John W LAWLER
-
依托单位:
THROMBOSPONDIN 4
-
批准号:2704648
-
项目类别:
-
资助金额:$32.32万
-
财政年份:1994
-
负责人:John W LAWLER
-
依托单位:
THROMBOSPONDIN-4
-
批准号:6776865
-
项目类别:
-
资助金额:$35.9万
-
财政年份:1994
-
负责人:John W LAWLER
-
依托单位:
THROMBOSPONDIN 4
-
批准号:6526829
-
项目类别:
-
资助金额:$36.38万
-
财政年份:1994
-
负责人:John W LAWLER
-
依托单位:
THROMBOSPONDIN-4
-
批准号:6883256
-
项目类别:
-
资助金额:$32.39万
-
财政年份:1994
-
负责人:John W LAWLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: